Acta Pharmaceutica Sinica B

Regulation of AMP-activated protein kinase by natural and synthetic activators
pp. 1-19(19)
Author: David Grahame Hardie

5'-Monophosphate-activated protein kinase (AMPK) improves autophagic activity in diabetes and diabetic complications
pp. 20-25(6)
Authors: Fan Yao; Ming Zhang; Li Chen

Direct anti-HCV agents
pp. 26-31(6)
Author: Xingquan Zhang

Structural optimization and biological evaluation of 1,5-disubstituted pyrazole-3-carboxamines as potent inhibitors of human 5-lipoxygenase
pp. 32-45(14)
Authors: Yu Zhou; Jun Liu; Mingyue Zheng; Shuli Zheng; Chunyi Jiang; Xiaomei Zhou; Dong Zhang; Jihui Zhao; Deju Ye; Mingfang Zheng; Hualiang Jiang; Dongxiang Liu; Jian Cheng; Hong Liu

Sesquiterpene glycosides from the roots of Codonopsis pilosula
pp. 46-54(9)
Authors: Yueping Jiang; Yufeng Liu; Qinglan Guo; Chengbo Xu; Chenggen Zhu; Jiangong Shi

Development and validation of an HPLC–MS/MS method to determine clopidogrel in human plasma
pp. 55-63(9)
Authors: Gangyi Liu; Chunxia Dong; Weiwei Shen; Xiaopei Lu; Mengqi Zhang; Yuzhou Gui; Qinyi Zhou; Chen Yu

Pharmacokinetic study of gallocatechin-7-gallate from Pithecellobium clypearia Benth. in rats
pp. 64-70(7)
Authors: Chao Li; Xiaowei Song; Junke Song; Xiaocong Pang; Zhe Wang; Ying Zhao; Wenwen Lian; Ailin Liu; Guanhua Du

Implementation of a reference-scaled average bioequivalence approach for highly variable generic drug products of agomelatine in Chinese subjects
pp. 71-78(8)
Authors: Fang Tang; Rui Zhou; Zeneng Cheng; Guoping Yang; Aiqiao Chen; Zhi Liu; Hongyi Tan; Shuang Yang; Sanwang Li; Lingli Mu; Peng Yu

Factors to consider in developing individual pharmaceutical product quality risk profiles useful to government procurement agencies
pp. 79-92(14)
Authors: Wei Xu; Garth Boehm; Qiang Zheng

Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer
pp. 93-99(7)
Authors: Danqi Chen; Aijun Shen; Guanghua Fang; Hongchun Liu; Minmin Zhang; Shuai Tang; Bing Xiong; Lanping Ma; Meiyu Geng; Jingkang Shen